- Change Language
- Home
- Overview
- Subscribers
- Locations
- Newsroom
The European Centre for Disease Prevention and Control (ECDC) have published a further interim report into their multi-country study into vaccine effectiveness against severe acute respiratory infection (SARI) due to confirmed COVID-19 in adults over the age of 30. This interim report follows up after similar analysis published in October 2021 and January 2022 and this report additionally includes data from adults aged 30-49 years old. The results presented in this report suggest a high adjusted vaccine effectiveness in preventing SARI associated with laboratory-confirmed SARS-CoV-2 infection for COVID-19 vaccines deployed during the first 12 months of the vaccination campaign across EU/EEA countries in all age groups 30 years and older, albeit with wide confidence intervals.
Read more about the ECDC’s interim analysis of COVID-19 vaccines from January here.
Additional data provided by
English
Japanese
